Financial Consulate »

Candel Therapeutics shares owned by Financial Consulate

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Financial Consulate from 13F filings

Historical chart of Financial Consulate investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Financial Consulate consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Financial Consulate

Quarter filed Position value Share count Share price at filing
2026-09-30 $1.7k 164 10.45

More positions owned by Financial Consulate

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Dfa Invt Dimensions Group In U.s. High Relati (DUHP)
Pimco Equity Ser Rafi Dyn Multi (MFDX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Dimensional Etf Trust Intl High Profit (DIHP)
Ishares Tr Trust Ishare 0-1 (SHV)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Dimensional Etf Trust Us Small Cap Etf
Schwab Strategic Tr Fundamental Us B (FNDB)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Apple (AAPL)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Schwab Strategic Tr Fund Em Equi Etf (FNDE)
T Rowe Price Exchange-traded Cap Appreciation (TCAF)

View all positions for Financial Consulate

Top funds holding Candel Therapeutics

FMR
Rtw Investments
BlackRock
State Street Corporation
Acorn Capital Advisors
Portolan Capital Management
Saturn V Capital Management
Vanguard Capital Management
Geode Capital Management
Millennium Management
Northern Trust
Kennedy Capital Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust
Sands Capital Ventures

View all funds holding Candel Therapeutics